89bio Inc Ordinary Shares (NASDAQ:ETNB)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - ETNB
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ETNB
- Market Cap$412.090m
- SymbolNASDAQ:ETNB
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS2825591033
Company Profile
89bio Inc a United States-based clinical-stage biopharmaceutical company focused on the development of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, BIO89-100, is a long-acting glycopegylated fibroblast growth factor 21 (FGF21) analogue.
Latest ETNB news
Currently there for this company. Visit our news hub for other news .